{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VT\",,,,,undefined,":{"symbol":"VT","market":"US","secType":"STK","nameCN":"Vanguard Total World Stock ETF","latestPrice":111.18,"timestamp":1744920000000,"preClose":110.6,"halted":0,"volume":1728825,"hourTrading":{"tag":"盘后","latestPrice":111.2,"preClose":111.18,"latestTime":"19:59 EDT","volume":1611,"amount":179471.633,"timestamp":1744934374973},"delay":0,"floatShares":366324146,"shares":366324146,"eps":0,"marketStatus":"Market Closed","change":0.58,"latestTime":"04-17 16:00:00 EDT","open":111.23,"high":111.9795,"low":110.705,"amount":192612905.48325,"amplitude":0.011524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":110.6,"sharesOutstanding":366328344,"nav":111.07,"aum":40688089168.08,"bidAskSpread":0.000495,"preHourTrading":{"tag":"盘前","latestPrice":111.33,"preClose":110.6,"latestTime":"09:29 EDT","volume":640,"amount":71365.5552,"timestamp":1744896599112},"postHourTrading":{"tag":"盘后","latestPrice":111.2,"preClose":111.18,"latestTime":"19:59 EDT","volume":1611,"amount":179471.633,"timestamp":1744934374973},"volumeRatio":0.5579037835008075,"impliedVol":0.2264,"impliedVolPercentile":0.9641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VT\",,,,,undefined,":{"symbol":"VT","floatShares":366324146,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5579037835008075,"shares":366324146,"dividePrice":2.2579,"high":111.9795,"amplitude":0.011524,"preClose":110.6,"low":110.705,"week52Low":100.89,"pbRate":"--","week52High":123.98,"institutionHeld":0,"latestPrice":111.18,"eps":0,"divideRate":0.020309,"volume":1728825,"delay":0,"ttmEps":0,"open":111.23,"prevYearClose":117.48,"prevWeekClose":111.11,"prevMonthClose":115.95,"prevQuarterClose":115.95,"fiveDayClose":108.86,"twentyDayClose":118.25,"sixtyDayClose":121.24},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VT\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.00182},{"market":"US","name":"Fractional Shares","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.001816}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528714618","title":"Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2528714618","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528714618?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:30","pubTimestamp":1744893000,"startTime":"0","endTime":"0","summary":"Agency’s Breakthrough Device Designation Program Allows for Priority Review of Ablation Technology for Ventricular Tachycardia. \"Receiving Breakthrough Device Designation is an important milestone for Adagio, validating our proprietary vCLASTM Cryoablation System with our ULTC technology as a potentially unique solution for the large, underserved population of patients suffering from ventricular tachycardia,\" said Todd Usen, Chief Executive Officer of Adagio. \"Our team has been working hard to bring this transformational technology to patients, and we are thrilled to be the only technology to be granted Breakthrough Device designation for endocardial treatment of both ischemic and nonischemic structural heart disease patients with sustained monomorphic VT. We are encouraged that, based in part on the strength of the clinical data from our European CRYOCURE-VT study, the FDA has determined that vCLASTM qualifies as a Breakthrough Device, and we look forward to working collaboratively wi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adagio-medical-holdings-inc-receives-123000953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADGM","BK4585","VT","BK4588","BK4082"],"gpt_icon":0},{"id":"2526524565","title":"Imricor Launches Groundbreaking VISABL-VT Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2526524565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526524565?lang=en_us&edition=fundamental","pubTime":"2025-04-11 08:08","pubTimestamp":1744330100,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ) has issued an update. Imricor Medical Systems, Inc. has initia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/imricor-launches-groundbreaking-visabl-vt-clinical-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/imricor-launches-groundbreaking-visabl-vt-clinical-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","VT"],"gpt_icon":0},{"id":"2526419364","title":"Merit Medical Launches the Ventrax™ Delivery System","url":"https://stock-news.laohu8.com/highlight/detail?id=2526419364","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526419364?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:25","pubTimestamp":1744205100,"startTime":"0","endTime":"0","summary":"Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardiaSOUTH JORDAN, Utah, April  09, 2025  (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058524/8028/en/Merit-Medical-Launches-the-Ventrax-Delivery-System.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU1814569148.SGD","LU1064131342.USD","LU0289739343.SGD","EP","IE00BQXX3F31.USD","LU0198837287.USD","LU2361044865.SGD","LU0719512351.SGD","LU1804176565.USD","LU0130102774.USD","LU2361045086.USD","LU0187121727.USD","LU0267386448.USD","IE00B19Z8X17.USD","LU0792757196.USD","LU2756315664.SGD","BK4588","IE00BZ1G4Q59.USD","LU0124676726.USD","LU0057025933.USD","LU1316542783.SGD","LU1989764664.SGD","CRM","BK4532","LU0081259029.USD","LU0354030438.USD","LU2087625088.SGD","LU2244417387.USD","LU0511384066.AUD","LU1551013342.USD","LU1267930813.SGD","MMSI","LU1548497426.USD","LU2264538146.SGD","LU0820561909.HKD","LU1989764748.USD","LU0889566641.SGD","LU2286300806.USD","VT","BK4607","LU1791710400.SGD","LU2361044949.HKD","LU0238689110.USD","IE00BQXX3C00.GBP","LU0889565833.HKD","BK4023","IE00BJTD4N35.SGD","IE00BQXX3D17.EUR","BK4561"],"gpt_icon":0},{"id":"2523949360","title":"Press Release: Adagio Medical Reports Fourth Quarter and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2523949360","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523949360?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:30","pubTimestamp":1743424200,"startTime":"0","endTime":"0","summary":"Adagio Medical Holdings, Inc. , a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported financial results for the fourth quarter and full year ended December 31, 2024.-- Reported total company revenue of $137 thousand in the fourth quarter of. revenue for 2024 was $0.6 million compared to $0.3 million in 2023.-- Surpassed 40% enrollment in the FULCRUM-VT pivotal study. The results of. the study will be used to support FDA premarket approval  for. Adagio's VT Cryoablation System for endocardial ablation of scar-mediated. ventricular tachycardia . The study, which seeks to enroll 206. centers, is on track for completion of patient enrollment in the second. US pivotal investigational device exemption clinical trial activities and. -- Reported cash, cash equivalents, and short-term investments of $20.6. Operating expenses for the fourth quarter of 2024 were $56.7 million, compared to $5.1 million for the fourth quarter of 2023. The inc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","ADGM","BK4588","VT","BK4099","BK4604","03160","BK4555","BK4585","BK4082"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VT\",params:#limit:5,,,undefined,":[{"date":"2025-03-21","symbol":"VT","amount":0.3852,"announcedDate":"2025-03-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-25","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-25"},{"date":"2024-12-20","symbol":"VT","amount":0.8774,"announcedDate":"2024-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-09-20","symbol":"VT","amount":0.4174,"announcedDate":"2024-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-20","defaultRemindTime":1726839000000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-24","payableDate":"2024-09-20","currency":"USD","dateTimestamp":1726804800000,"payDate":"2024-09-24"},{"date":"2024-06-21","symbol":"VT","amount":0.5779,"announcedDate":"2024-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"世界全股市ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"},{"date":"2024-03-15","symbol":"VT","amount":0.4212,"announcedDate":"2024-03-13","type":"dividend","market":"US","newRecordDate":"2024-03-18","defaultRemindTime":1710509400000,"name":"VANGUARD INTL EQUITY INDEX FUND INC TOTAL WORLD STK INDEX FUND ETF SHS","recordDate":"2024-03-20","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1710475200000,"payDate":"2024-03-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VT\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-26","recordDate":"2015-06-30","paymentDate":"2015-07-02","value":0.453,"currency":"USD"},{"executeDate":"2015-09-25","recordDate":"2015-09-29","paymentDate":"2015-10-01","value":0.279,"currency":"USD"},{"executeDate":"2015-12-21","recordDate":"2015-12-23","paymentDate":"2015-12-28","value":0.368,"currency":"USD"},{"executeDate":"2016-03-15","recordDate":"2016-03-17","paymentDate":"2016-03-21","value":0.222,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-20","value":0.466,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VT\",market:\"US\",delay:false,,,undefined,":{}}}